Liv Solvår Nymark Method Development and Analytics Les på norsk Projects and publications Scientific articles and book chapters Liv Solvår Nymark, Jacob Dag Berild, Trude Marie Lyngstad, Brita Askeland Winje, Didrik Frimann Vestrheim, Ingeborg Aase S. Aaberge, Lene Kristine Juvet, Ellen Wolff, (2022). Cost-utility analysis of the universal pneumococcal vaccination programme for older adults in Norway. Human Vaccines & Immunotherapeutics doi: 10.1080/21645515.2022.2101333 Nicolas Yin, Simon Dellicour, Valery Daubie, Nicolas Franco, Magali Wautier, Christel Faes, Dieter Van Cauteren, Liv Solvår Nymark, Niel Hens, Marius Gilbert, Marie Hallin, Oliver Vandenberg, (2021). Leveraging of SARS-CoV-2 PCR cycle thresholds values to forecast COVID-19 trends. Frontiers in medicine doi: 10.3389/fmed.2021.743988 Liv Solvår Nymark, Alex Miller, Anna Vassall, (2021). Inclusion of Additional Unintended Consequences in Economic Evaluation: A Systematic Review of Immunization and Tuberculosis Cost-Effectiveness Analyses. PharmacoEconomics - Open doi: 10.1007/s41669-021-00269-4 Liv Solvår Nymark, Vassall Anna, (2020). A comprehensive framework for considering additional unintended consequences in economic evaluation. Cost Effectiveness and Resource Allocation doi: 10.1186/s12962-020-00218-8 Liv Solvår Nymark, Alexander Miller, Sharma Tarang, Ulrika Enemark, Ulla Griffiths, (2017). Inclusion of the value of herd immunity in economic evaluations of vaccines. A systematic review of methods used. Vaccine doi: 10.1016/j.vaccine.2017.10.024 Liv Solvår Nymark, Paul Davies, Omid Shabestari, Iain McNeil, (2013). Analysis of the Impact of the Birmingham OwnHealth Program on Secondary Care Utilization and Cost: A Retrospective Cohort Study. Telemedicine journal and e-health doi: 10.1089/tmj.2013.0011 Others Liv Solvår Nymark, (2021). Kan vi oppnå full effekt av helseintervensjoner?. Dagens medisin Contact Visiting address Lovisenberggata 8, 0456 Oslo View on map
